בורטזומיב פרזניוס קבי 3.5 מ"ג - Bortezomib fresenius kabi 3.5 mg

× ×ª×× × ×ª×¨××¤×

×××¨×©×

××× ×× ×× × ××¡×¤××	×××¨×××××× - ×ª×¨××× - Bortezomib - trima ×××¨×××××× ××××¨ ×¤××¨×× 2.5 ××/×"× - Bortezomib ever pharma 2.5 mg/ml ×××¨×××××× ××× ×××× 3.5 ××' - Bortezomib inovamed 3.5 mg ×××¨×××××× ××××× - Bortezomib medomie ×××¨×××××× ××¡.×§××. 3.5 ××' - Bortezomib s.k. 3.5 mg ×××¨×××××× ×ª×¨× 3.5 ×"× - Bortezomib taro 3.5 mg ×××¨××××××× ×××¢ 1 ×"× - Bortezomib teva 1 mg ×××¨×××××× ×××¢ 2.5 ×"× - Bortezomib teva 2.5 mg ×××¨×××××× ×××¢ 3.5 ×"× - Bortezomib teva 3.5 mg
×§×××¦× ×¤×¨××§××××××ª (ATC4)	L01XG Proteasome inhibitors
××¨××× ×¤×¢×× (ATC5)	Â Bortezomib 3.5 MG/VIAL âL01XG01
×¦××¨×ª ××ª×	×ª××-××¨×××, ×ª×ª-×¢××¨× - I.V, S.C
×¦××¨×ª ××× ××	×××§× ×××× ×ª ×ª×××¡× ×××¨××§×, POWDER FOR SOLUTION FOR INJECTION ××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××
××ª××××	Multiple MyelomaBortezomib Fresenius Kabi is indicated for the treatment of adult patients with multiple myeloma.Mantle Cell LymphomaBortezomib Fresenius Kabi for injection is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. Bortezomib Fresenius Kabi in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation.
×¢××× ××¨××¤× ×××××¨××ª ××¢×××	Â ×¢××× ××¨××¤× 08.05.2023 Â ××××¨× ××¢××× 08.05.2023 ××××¨× ××¢××× 13.12.2022

×¢××× ××¦×¨××	Â

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
×××¨×××××× ×¤×¨×× ×××¡ ×§×× 3.5 ×"× ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	××××¨×× ×-PubMed
××××¢ ××¨×©×ª	RxList WebMD Drugs.com
×©× ××¦×¨×	FRESENIUS KABI ONCOLOGY LIMITED, INDIA
×©× ××¢× ××¨××©××	NEOPHARM (ISRAEL) 1996 LTD
×¨××©×××	×ª××¨×× ×××©×: 10/2021. ×¨××©××× ××ª××¨××:
×ª××¨×× ×¢×××× ×××¨××	17/03/24

השינוי האחרון נעשה בֹ־22 ביוני 2025 ב־01:56